http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018101267-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
filingDate 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_922629dcf1e7dcc7ffdbe36196d6f1b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e3aff96e12d92e72d484b0e32d4092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b882cf4e085d6270653c3cc4285005dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17b19252f0c272b76112288a3f541214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5f7fd54beae202fcc04e4d2695618f4
publicationDate 2018-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018101267-A1
titleOfInvention Oral agent
abstract The purpose of the present invention is to provide an oral agent that includes sparingly soluble components, wherein the oral agent can exhibit excellent dispersibility. The present invention is an oral agent including component (A): sparingly soluble components such as lutein, capsanthin, zeaxanthin, β-cryptoxanthin, docosahexaenoic acid, astaxanthin, and β-carotene; and component (B): organic acid monoglycerides such as citric acid monoglyceride, diacetyl tartaric acid monoglyceride, lactic acid monoglyceride, and succinic acid monoglyceride; and optionally including component (C): a hydrophilic emulsifier having an HLB of 10 or higher.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020105078-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111358000-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7032260-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020015669-A
priorityDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007051115-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007052738-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008044659-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5368397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226489718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409186

Total number of triples: 51.